Coffee could offer key ingredient for new treatments for Parkinson's disease
Monday, September 5, 2011 - 08:01
in Health & Medicine
Scientists from Heptares Therapeutics have used Diamond Light Source, the UKs national synchrotron facility, to understand the structure of a protein involved in Parkinsons disease and other neurological disorders. Their findings, published this week in the journal Structure, could pave the way for a new generation of targeted drug treatments.